glp 1 medication hair loss after starting a GLP-1 left this patient feeling discouraged, but these early results show what's possible with the right support. This before and after reflects improvement after the first New Study Finds Use of

PubMed Effect of glucagon-like peptide-1 receptor agonists and co-agonists on body composition Supports body-composition, lean-mass, and metabolic-risk context

doi:10.1016/j.amjmed.2025.01.016 Wharton S, Lingvay I, Bogdanski P, et al

Semaglutide has additional benefits, often improving vital health markers associated with obesity-related conditions like heart disease and type 2 diabetes

Summary and clinical implications Current clinical and preclinical data suggest a complex relationship between GLP-1RAs and the risk of PDAC (Fig

Given the tissue-specific nature of these receptor activation effects, precise targeting of glucagon-family receptors is necessary to provide sufficient treatment for metabolic disease, while also limiting any adverse effects